Document:

Exhibit 10.1

 

Subscription Agreement

 

 

	To:	Umbra Companies, Inc.
	 	1999 Avenue of the Stars
	 	Suite 1100-B
	 	Century City, CA 90067.

 

Gentlemen:

 

1.       Subscription.
The undersigned hereby subscribes for ______ Notes of Umbra Companies, Inc. (the “Company”), a Colorado
corporation, and agrees to loan to the Company One Million ($1,000,000) Dollars per Note for an aggregate loan of $________ (the
“Loan Amount”) upon the terms and subject to the conditions (a) set forth herein, and (b) described in the Confidential Private
Placement Memorandum (“Private Placement Memorandum”) dated ____________, 20________ together with all exhibits thereto and
materials included therewith, and all supplements, if any, related to this offering. The minimum loan is One Million ($1,000,000) Dollars,
but the Company has the discretion to offer fractional Notes for loans less than the minimum.

 

2.       Note
Offering. The Company is offering a minimum of One (1) and up to a maximum of One Hundred and Twenty Five (125) Notes at One Million
($1,000,000) Dollars per Note, with a minimum subscription of one (1) Note (the “Offering”). The minimum aggregate loan to
the Company will be One Million ($1,000,000) Dollars and the maximum aggregate loan to the Company from this Offering will be One Hundred
and Twenty Five ($125,000,000) Dollars. The Offering is being made to a limited number of investors pursuant to an exemption available
under the Securities Act of 1933 (the “Act”), specifically Rule 506 promulgated under Regulation D, and under certain other
laws, including the securities law of certain states.

 

3.       Documents
to be Delivered. The undersigned is delivering to the Company executed copies of this Subscription Agreement (the “Agreement”),
the Note(s), Investor Suitability Questionnaire, and all other applicable exhibits and documents
(the “Subscription Documents”). The Subscription Documents should be delivered to Umbra Companies, Inc., at 1999 Avenue of
the Stars, Suite 1100-B, Century City, CA 90067. The undersigned understands and agrees that he or it will not become a “Holder”
of the Note(s) and the Company shall not become a “Maker” of the Note(s) unless and until the Agreement and Note(s) are executed
by the Company.

 

4.       Making
of Loan Amount. The undersigned, simultaneously with the delivery of the Subscription Documents to the Company, hereby tenders to
the Company the Loan Amount by check made payable to the order of Umbra Companies, Inc. in the amount indicated above.

 

5.       Acceptance
or Rejection of Subscription. The undersigned understands and agrees that the Company reserves the right, exercisable in its sole
discretion, to accept or reject any subscription, in whole or in part, for any reason and that the undersigned will be notified by the
Company as promptly as practicable as to whether his or its subscription has been accepted or rejected. If the undersigned's subscription
is accepted, in whole or in part, by the Company, the Company will execute this Agreement and the Note(s) and return them to the undersigned.
If this subscription is rejected by the Company, either in whole or in part, all funds, in the case of a rejection of the subscription
in whole, or those funds representing the amount of the subscription not accepted by the Company, in the case of a rejection of the subscription
in part, will be returned to the undersigned as promptly as practicable. If this subscription is rejected in whole by the Company, this
Agreement shall be null, void and of no effect. The undersigned does not have the right to withdraw or revoke his or its subscription
during the Offering period, except as provided by certain state laws, except that if more than thirty (30) days shall have passed from
the date the Company received completed and executed Subscription Documents and the Loan Amount from the undersigned (the “Acceptance
Period”), and the Company has not accepted the subscription during the Acceptance Period, the undersigned may withdraw his or its
subscription at any time after the Acceptance Period up until such time that the Company subsequently decides, in its sole discretion,
to accept the subscription in whole or in part.

 

6.       Offering
Period.The Company may close in whole or in part or terminate this Offering under any of the following conditions:

1.       Upon
reaching the minimum offering amount of One Million ($1,000,000) Dollars

 

2.       Upon
receipt of the maximum offering subscription amount of One Hundred and Twenty Five Million ($125,000,000) Dollars

 

 

 

    	 	1	 

     

    

 

3.       Notwithstanding
the above, this offer shall terminate one (1) year from the date of this Private Placement Memorandum; or on such later date not exceeding
thirty (30) days thereafter to which the Company, in its sole discretion, may extend this Offering.

 

7.       Closing
of the Loan. The Note(s) subscribed for herein shall not be deemed made by the Company or held by the undersigned until this Agreement
and the Note(s) have been countersigned by the Company, and until the funds delivered by the undersigned to the Company with the Subscription
Documents have been deposited in the Holding Account and have been cleared by the applicable bank of the Company (the “Effective
Date”). Upon the Effective Date, (a) the undersigned shall have loaned to the Company the Loan Amount, (b) the undersigned shall
become the Holder and the Company shall become the Maker of the Note(s) subscribed for by the undersigned, and (c) both the undersigned
and the Company shall be bound by the terms of the Private Placement Memorandum and the Subscription Documents and any other undertakings
described herein.

 

8.       Representations
and Warranties.

 

(a)       The
Company hereby represents and warrants as follows:

 

(i)       The
Company is a corporation duly organized, validly existing and in good standing under the laws of the State of Colorado and has the requisite
corporate power and authority to own, lease and operate its properties and to carry on its business as now being conducted;

 

(ii)       This
Agreement constitutes the valid and binding obligation of the Company enforceable against the Company in accordance with its terms (except
as such enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws from time to time
in effect which affect creditor’s rights generally and by legal and equitable limitations on the availability of specific performance
and other equitable remedies under or by virtue of this Agreement). The Company has all requisite power and authority, corporate and other,
to execute and deliver this Agreement and the Note(s) and to consummate the transactions contemplated hereby. All persons who have executed
this Agreement and the Note(s) on behalf of the Company have been duly authorized to do so by all necessary corporate action. Neither
the execution and delivery of this Agreement and the Note(s) nor the consummation of the transactions contemplated hereby will (A) violate
any provision of the Certificate of Incorporation or by-laws of the Company, as currently in effect; (B) violate any judgment, order,
injunction, decree or award against, or binding upon, the Company or the securities, assets, properties, operations or business of the
Company; or (C) violate any law or regulation applicable to the Company or to the securities, assets, properties, operations or business
of the Company.

 

(b)       In
order to induce the Company to accept the subscription made hereby, the undersigned hereby represents and warrants to the Company as follows:

 

(i)       The
undersigned has received the Private Placement Memorandum and the Subscription Documents. The undersigned has read and understands the
Private Placement Memorandum and Subscription Documents and the information contained in those documents concerning the Company and this
Offering or has caused his or its representative to read and examine the Private Placement Memorandum and Subscription Documents. The
undersigned has relied only on the information about the Company contained in these documents and his or its own independent investigation
in making his or its subscription. The undersigned understands that the Notes will be issued with the rights and subject to the conditions
described in the Private Placement Memorandum and Subscription Documents;

 

(ii)       The
undersigned is familiar with the terms and conditions of the Offering and is aware that his or its investment involves a degree of risk
and the undersigned has read the section in the Private Placement Memorandum titled “Risk Factors.”

 

(iii)       The
undersigned hereby specifically accepts and adopts each and every provision of this Agreement and acknowledges and agrees with each and
every provision of this Agreement and, upon acceptance by the Company of the subscription made hereby, agrees to be bound by such provisions.

 

 

 

    	 	2	 

     

    

 

(iv)       The
undersigned acknowledges and is aware that there is no assurance as to the future performance of the Company.

 

(v)       The
undersigned, if an individual (A) has reached the age of majority in the state in which he resides and (B) is a bona fide resident and
domiciliary (not a temporary or transient resident) of the state set forth below his signature on the signature page hereof and has no
present intention of becoming a resident of any other state or jurisdiction. The undersigned, if a partnership, corporation, limited liability
company, trust or other entity, was organized or incorporated under the laws of the jurisdiction set forth below the signature made on
its behalf on the signature page hereof and has no present intention of altering the jurisdiction of its organization, formation or incorporation.

 

(vi)       The
undersigned has the financial ability to bear the economic risk of an investment in the Offering, has adequate means of providing for
his or its current needs and personal contingencies, has no need for liquidity in the Note(s) and could afford a complete loss of his
or its investment in the Offering.

 

(vii)       The
undersigned represents and warrants to the Company that he or it comes within one of the categories of investors as defined in Exhibit
1 hereto (please indicate by providing your initials next to the appropriate category in which the undersigned is included, and if
the undersigned is an Accredited Investor, check the appropriate category of Accredited Investors in which the undersigned is an entity).

 

(viii)       The
undersigned has been given the opportunity to review the merits of an investment in the Offering with tax and legal counsel or with an
investment advisor to the extent the undersigned deemed advisable.

 

(ix)       The
undersigned's overall commitment to invest in the Note(s), which are not readily marketable, is not disproportionate to his or its net
worth and his or its investment in the Offering will not cause such overall commitment to become excessive.

 

(x)       The
undersigned has such knowledge and experience in financial and business matters that he or it is capable of evaluating the merits and
risks of an investment in the Offering.

 

(xi)       The
undersigned has been given a full opportunity to ask questions of and to receive (A) answers from the Company and its officers and directors
concerning the terms and conditions of this Offering and the business of the Company and (B) such other information as he or it desired
in order to evaluate an investment in the Offering, and all such questions have been answered to the full satisfaction of the undersigned.
No oral or written representations have been made or oral or written information furnished to the undersigned or the undersigned's advisors
in connection with the Offering or interests that were in any way inconsistent with this Subscription Agreement.

 

(xii)       If
the undersigned is a corporation, limited liability company, partnership, trust or other entity, it is authorized and qualified to make
this loan to the Company and the person signing this Agreement on behalf of such entity has been duly authorized by such entity to do
so.

 

(xiii)       If
the undersigned is a corporation, limited liability company or partnership, the person signing this Agreement on its behalf hereby represents
and warrants that the information contained in this Agreement completed by any shareholders of such corporation, members of such limited
liability company or partners of such partnership is true and correct with respect to such shareholder, member or partner (and if any
such shareholder is itself a corporation, limited liability company or partnership, with respect to all persons having an equity interest
in such corporation, limited liability company or partnership, whether directly or indirectly) and that the person signing this Agreement
has made due inquiry to determine the truthfulness and accuracy of the information contained in this Agreement.

 

(xiv)       The
purchase of the Note(s) by the undersigned has been duly authorized, and the execution, delivery and performance of this Agreement does
not conflict with the undersigned's partnership agreement, certificate of incorporation, by-laws, articles of organization, operating
agreement or any agreement to which the undersigned is a party and this Agreement is a valid and binding agreement enforceable against
the undersigned in accordance with its terms.

 

 

 

    	 	3	 

     

    

 

(xv)       The
undersigned hereby represents that he or it is subscribing for the Notes as principal or as trustee, solely for the account of the undersigned,
for investment purposes only and not with a view to, or for, subdivision, resale, distribution, or fractionalization thereof, in whole
or in part, or for the account, in whole or in part, of others, and, except as disclosed herein, no other person has a direct or indirect
beneficial interest in the Note(s). The undersigned will hold the Note(s) as an investment and has no reason to anticipate any change
in circumstances or other particular occasion or event, which would cause the undersigned to attempt to sell any of the Note(s).

 

(xvi)       The
undersigned acknowledges his or its understanding that (A) the Offering of the Note(s) by the Company has not been registered under the
Act, as amended, or the securities laws of certain states in reliance on specific exemptions from registration, (B) the Confidential Memorandum
and Subscription Documents have not been filed with or reviewed by the Securities and Exchange Commission or the securities department
of any state and no securities administrator of any state or the federal government has recommended or endorsed this Offering or made
any finding or determination relating to the fairness of an investment in the Company, and (C) the Offering of the Note(s) by the Company
is intended to be exempt from registration pursuant to Section 4 (2) of the Act and the rules promulgated thereunder by the Securities
and Exchange Commission, and that the undersigned’s Note(s) cannot be sold, pledged, assigned or otherwise disposed of unless they
are registered under the Act or an exemption from such registration is available.

 

(xvii)       The
undersigned represents and warrants that he or it will not transfer or convey all or part of his or its financial interest in the Note(s)
unless such Note(s) are subsequently registered under the Act, or an exemption from such registration is available and without (A) the
prior written consent of the Company and (B) an opinion of counsel acceptable to the Company and its counsel to the effect that the Note(s)
may be transferred without violation of the registration requirements of the Act or any applicable state securities laws, as may be amended
from time to time. The undersigned further acknowledges that there can be no assurance that the Company will file any registration statement
for the Note(s) for which the undersigned is subscribing, that such registration statement, if filed, will be declared effective or, if
declared effective, that the Company will be able to keep it effective until the undersigned sells the Note(s) registered thereon.

 

(xviii)       The
undersigned understands that this Agreement is subject to the Company’s acceptance and may be rejected by the Company at any time
in its sole discretion in whole or any part prior to issuance of the Note(s) with respect to the undersigned’s subscription, notwithstanding
prior receipt by the undersigned of notice of acceptance of the undersigned’s subscription. The Company reserves the right to withdraw
the Offering at any time.

 

(xix)       The
undersigned acknowledges that this Agreement shall become binding upon the undersigned when it is countersigned by the Company and the
undersigned is not entitled to cancel, terminate, or revoke this subscription before or after acceptance by the Company, except as otherwise
provided in this Agreement.

 

(xx)       All
information provided by the undersigned in the Investor Suitability Questionnaire which accompanies this Agreement is true and accurate
in all respects, and the undersigned acknowledges that the Company will be relying on such information to its possible detriment in deciding
whether the Company can make these Note(s) to the undersigned without giving rise to the loss of an exemption from registration under
the applicable securities laws.

 

9.       Foreign
Person. If the undersigned has indicated on the signature page of this Agreement that he, she or it is a foreign person, he, she or
it agrees to notify the Company in writing within sixty (60) days of becoming a nonresident alien, foreign corporation, foreign partnership,
foreign trust, foreign estate or other foreign entity, as the case may be.

 

10.       Indemnity.
The undersigned agrees to indemnify and hold harmless the Company, its officers, directors, shareholders, agents, attorneys and affiliates
and each other person, if any, who controls any thereof, within the meaning of Section 15 of the Act, against any and all loss, liability,
claim, damage and expense whatsoever (including, but not limited to, any and all expenses reasonably incurred in investigating, preparing
or defending against any litigation commenced or threatened or any claim whatsoever) arising out of or based upon any false representation
or warranty or breach or failure by the undersigned to comply with any covenant or agreement made by the undersigned herein or in this
Agreement or in any other document furnished by the undersigned to any of the foregoing in connection with this transaction.

 

 

 

    	 	4	 

     

    

 

11.       Notice.
All notices in connection with this Agreement shall be in writing and personally delivered or delivered via overnight mail, with written
receipt therefor, or sent by certified mail, return receipt requested, to each of the parties hereto at their addresses set forth above
(or such other address as may hereafter be designated by either party in writing in accordance with this Section 11) with a copy, in the
case of notice to the Company, to Umbra Companies, Inc., at 1999 Avenue of the Stars, Suite 1100-B, Century City, CA 90067. Such notice
shall be effective upon personal or overnight delivery or five (5) days after mailing by certified mail.

 

12.       Miscellaneous.

 

(a)       This
Agreement is not assignable by the undersigned. This Agreement shall be binding upon and shall inure to the benefit of the parties, their
successors and, subject to the above limitation, their assigns, and shall not be enforceable by any third party.

 

(b)       This
Agreement shall be deemed to have been made in the State of Colorado and any and all performance
hereunder, or breach thereof, shall be interpreted and construed pursuant to the laws of the State of Colorado
without regard to conflict of laws rules applied in State of Colorado. The parties hereto
hereby consent to personal jurisdiction and venue exclusively in the State of Colorado with respect
to any action or proceeding brought with respect to this Agreement.

 

(c)       This
Agreement contains all oral and written agreements, representations and arrangements between the parties with respect to its subject matter,
and no representations or warranties are made or implied, except as specifically set forth herein. No modification, waiver or amendment
of any of the provisions of this Agreement shall be effective unless in writing and signed by both parties to this Agreement.

 

(d)       No
waiver of any breach of any terms of this Agreement shall be effective unless made in writing signed by the party against whom enforcement
of the waiver is sought, and no such waiver shall be construed as a waiver of any subsequent breach of that term or of any other term
of the same or different nature.

 

(e)       If
any provision or portion of this Agreement or the application thereof to any person or party or circumstances shall be invalid or unenforceable
under applicable law, such event shall not affect, impair, or render invalid or unenforceable the remainder of this Agreement.

 

(f)       Each
of the parties hereto shall cooperate and take such actions, and execute such other documents, at the execution hereof or subsequently,
as may be reasonably requested by the other in order to carry out the provisions and purposes of this Agreement.

 

IN WITNESS WHEREOF, the undersigned,
by his or its execution hereof, agrees to be bound by this Agreement.

 

Executed this _______ day of __________________
, 2021, at ___________________ (City) , ______________________________ (State).

 

 

 

 

    	 	5	 

     

    

 

	If the Investor is an INDIVIDUAL, complete the following:
	
    The undersigned (circle one): [is] [is
    not] a citizen or resident of the United States.

     

     

     

	Print Name of Individual:	 	
    Print Name of Spouse if Funds are to be invested
    in Joint Name

     

     

     

	
    Print Social Security Number of Individual:

     

     

     

    _______________________
	 	Print Social Security Number of Spouse
	
    Signature of Individual

     

     
	 	
    Signature of Spouse if Funds are to be Invested
    in Joint Name

     

     

     

	Print Address of Residence:	 	

    Print Telephone Number:

    ( )

	 	 	 
	 	 	 

 

	
    If the investor is PARTNERSHIP, CORPORATION,
    TRUST OR OTHER ENTITY, complete the following:

     

	
    The undersigned (circle one) [is] [is not]
    a foreign partnership, foreign corporation, trust or foreign estate (as defined in the Internal Revenue Code of 1986, as amended, and
    the treasury regulations promulgated thereunder).

     

     

	
    Print Name of Partnership, Corporation, Trust or
    Entity:

     

     
	 	
    Title of Authorized Representative

     

	
    Signature of Authorized Representative

     
	 	
    Print Jurisdiction of Organization or Incorporation

     

     

	Print Name of Authorized Representative	 	
    Print Federal Tax Identification Number

     

     

	Print Address of Residence:	 	
    Print Telephone Number:

    ( )

	 	 	 
	 	 	 

 

 

 

    	 	6	 

     

    

 

ACCEPTANCE

 

The terms of the foregoing, including the subscription
described therein, are agreed to and accepted on this ____ day of ____________, 20___.

 

Umbra Companies, Inc.,

 

 

By: ___________________________________

 

 

 

 

 

 

 

 

 

 

    	 	7Exhibit
10.1

 

 

 

December
30, 2021

 

VIA
EMAIL AND COURIER

 

Biosight
LTD.

3
Hayarden St., Airport City

P.O.B
1083

Lod
7019802

Israel

E-Mail:
ruth@biosight-pharma.com

Attention:
Dr. Ruth Ben Yakar

 

Dear
Ruth:

 

I
am writing in connection with the Agreement and Plan of Merger and Reorganization, dated as of July 4, 2021, among Advaxis, Inc., Advaxis,
Ltd., and Biosight LTD (the “Agreement”1). As you know, at the second reconvened Advaxis Stockholders’
Meeting, Advaxis’ stockholders did not approve Proposal 2 relating to the Reverse Split, which was necessary for Advaxis to issue
the Merger Consideration to the Biosight Shareholders. Accordingly, the Advaxis Stockholder Approval, which was a condition to the obligations
of each party under the Agreement, was not obtained. Because the Advaxis Stockholder Approval was not obtained, Advaxis hereby terminates
the Agreement pursuant to Section 9.1(b)(iv) of the Agreement, effective immediately.

 

We
regret that Advaxis and Biosight were unable to conclude the Transactions, but we look forward to opportunities to work with Biosight
in the future.

 

Very
truly yours,

 

Advaxis,
Inc.

 

	By:	/s/ Kenneth
    A. Berlin	 
	Name:	Kenneth
    A. Berlin	 
	Title:	Chief
    Executive Officer	 

 

Copies
to:

 

White
& Case LLP

3000
El Camino Real, 2 Palo Alto Square, Suite 900

Palo
Alto, CA 94306-2109

Telephone
No.: +1 650 213 0315

E-Mail:
tsealman@whitecase.com

Attention:
Tali Sealman

 

White
& Case LLP

1221
Avenue of the Americas

New
York, NY 10020-1095

Telephone
No.: +1 212 819 8754

E-Mail:
cdiamond@whitecase.com

Attention:
Colin Diamond

 

Horn
& Co. Law Offices

Amot
Investments Tower, 24th Floor

2
Weizmann St., Tel-Aviv, 6423902, Israel

Telephone
No.: +972-3-637 8200

E-Mail:
yhorn@hornlaw.co.il

Attention:
Adv. Yuval Horn

 

 

 

1
Capitalized terms used but not defined in this letter have the respective meanings ascribed thereto in the Agreement.

 

 

Advaxis,
Inc. / 9 Deer Park Drive, Suite K-1 / Monmouth Junction, NJ 08852

T:
609-452-9813 / F: 609-452-9818

www.advaxis.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00338-of-00352.parquet"}]]